RaDiCo Acostill study for inflammatory fevers and arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This is a long-term study that collects health information and lab samples from people who have certain diagnoses of recurring (coming and going) inflammatory fevers and related joint or immune conditions. It may help researchers better understand these diseases and how they work over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 16, or be 16 or younger with a specific type of juvenile arthritis diagnosis
- Have been told you meet the study’s diagnostic standards (Yamaguchi or Fautrel, or ILAR systemic juvenile idiopathic arthritis criteria)
- Be able to give consent (or have a parent/guardian agree if you are a minor)
- Be covered by France’s national health insurance system (Régime National d'Assurance Maladie)
- Not have fever from infections like tuberculosis, sepsis, or certain tumors like lymphoma
- Not have other specific immune conditions (for example rheumatoid arthritis, lupus, vasculitis, or known genetic auto-inflammatory syndromes)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with adult-onset Still's disease and similar autoinflammatory conditions to better understand these diseases. By joining, you contribute to research that may lead to better care in the future.
This study aims to learn more about the causes and genetics of two related inflammatory conditions: systemic juvenile idiopathic arthritis (sJIA) in children and adult-onset Still's disease (AOSD) in adults. By studying patients and healthy volunteers, researchers hope to understand these diseases better and find better ways to treat them.
This is a study looking back at patients who were already treated with a medicine called canakinumab for familial Mediterranean fever or Still's disease (rare conditions that cause fevers and joint pain). Researchers want to understand how well this medicine worked over time and what happened to patients who took it.
This study looks at the gut bacteria (microbiome) in people with autoinflammatory diseases. It may help researchers understand how bacteria in the gut affect inflammation and find better ways to treat these conditions.
This is a study that follows people with an immune-related illness at Lille University Hospital to better understand their care needs over time. By collecting information regularly, the study may help improve how future patients are monitored and treated.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
Hear when a new Still Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.